Molecure Management

Management Kriterienprüfungen 1/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Marcin Szumowski

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführerno data
Eigentum des Geschäftsführers0.7%
Durchschnittliche Amtszeit des Managements3.6yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder2.8yrs

Jüngste Management Updates

Recent updates

Is Molecure (WSE:MOC) In A Good Position To Deliver On Growth Plans?

Aug 20
Is Molecure (WSE:MOC) In A Good Position To Deliver On Growth Plans?

Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Apr 20
Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

We're Keeping An Eye On Molecure's (WSE:MOC) Cash Burn Rate

Dec 01
We're Keeping An Eye On Molecure's (WSE:MOC) Cash Burn Rate

Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Jul 07
Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Mar 10
Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Aug 16
Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

OncoArendi Therapeutics' (WSE:OAT) Earnings Are Weaker Than They Seem

Nov 04
OncoArendi Therapeutics' (WSE:OAT) Earnings Are Weaker Than They Seem

Is OncoArendi Therapeutics S.A.'s (WSE:OAT) Shareholder Ownership Skewed Towards Insiders?

Feb 24
Is OncoArendi Therapeutics S.A.'s (WSE:OAT) Shareholder Ownership Skewed Towards Insiders?

Will OncoArendi Therapeutics (WSE:OAT) Spend Its Cash Wisely?

Jan 02
Will OncoArendi Therapeutics (WSE:OAT) Spend Its Cash Wisely?

Geschäftsführer

Marcin Szumowski

no data

Amtszeit

zł548,043

Vergütung

Mr. Marcin Jan Szumowski, Ph D., is employed at Life Science Innovations Fund. He has been Chief Executive Officer and President of the Management Board at Molecure S.A. (formerly known as OncoArendi Thera...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Marcin Szumowski
Co-Founderno datazł548.04k0.70%
PLN 1.8m
Adam Golebiowski
Co-Founder & VP of Research Chemistry12.6yrszł500.00k3.01%
PLN 7.7m
Slawomir Broniarek
CFO & Member of the Management Boardno datazł414.20k0.20%
PLN 524.5k
Zbigniew Zaslona
Chief Scientific Officer & Member of Management Board2.6yrszł376.64k0.11%
PLN 287.1k
Agnieszka Rajczuk-Szczepanska
Member of Management Board & HR Director4.6yrszł345.44k0.034%
PLN 88.2k
Jacek Olczak
Co-Founder & Head of Medicinal Chemistryno datakeine Datenkeine Daten
Samson Fung
Chief Medical Officer & Member of Management Board1.6yrskeine Datenkeine Daten
Magdalena Tyszkiewicz
Head of CMC4.6yrskeine Datenkeine Daten
Marta Borkowska
Director of the Management Board Office2.6yrskeine Datenkeine Daten

3.6yrs

Durchschnittliche Betriebszugehörigkeit

Erfahrenes Management: MOCDas Führungsteam des Unternehmens gilt als erfahren (3.4 Jahre durchschnittliche Betriebszugehörigkeit).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Reynold A. Panettieri
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Bart Lambrecht
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Jakub Golab
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Tomasz Piec
Vice Chairman of the Supervisory Board4.6yrszł140.98kkeine Daten
Douglas Hay
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Rafal Kaminski
Member of the Supervisory Board2.6yrszł63.46kkeine Daten
Paul Van Der Horst
Member of Supervisory Board2.6yrszł117.62k0.059%
PLN 152.0k
Mariusz Gromek
Member of Supervisory Boardno datazł112.78kkeine Daten
Piotr Zólkiewicz
Independent Chairman of Supervisory Board3.6yrszł197.37kkeine Daten
Rafal Krenke
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Bruce Conway
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Nancy Van Osselaer
Member of the Supervisory Board & Member of Scientific Advisory Board2.8yrszł117.62kkeine Daten

2.8yrs

Durchschnittliche Betriebszugehörigkeit

Erfahrener Vorstand: MOCDie Vorstandsmitglieder gelten nicht als erfahren ( 2.7 Jahre durchschnittliche Amtszeit), was auf einen neuen Vorstand hindeutet.